Vui lòng sử dụng định danh này để trích dẫn hoặc liên kết đến tài liệu:
http://dspace.hmtu.edu.vn/handle/DHKTYTHD_123/374
Nhan đề : | Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment? |
Tác giả : | Fanale, Michelle |
Năm xuất bản : | 2013 |
Nhà xuất bản : | American Society of Hematology |
Tóm tắt : | Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a unique diagnostic entity, with only 500 new cases in the United States per year with a similar infrequent incidence worldwide. NLPHL also has distinctive pathobiology and clinical characteristics compared with the more common classical Hodgkin lymphoma (cHL), including CD20 positivity of the pathognomic lymphocytic and histiocytic cells and an overall more indolent course with a higher likelihood of delayed relapses. Given the limited numbers of prospective NLPHL-focused trials, management algorithms historically have typically been centered on retrospective data with guidelines often adopted from cHL and indolent B-cell lymphoma treatment approaches. Key recent publications have delineated that NLPHL has a higher level of pathological overlap with cHL and the aggressive B-cell lymphomas than with indolent B-cell lymphomas. Over the past decade, there has been a series of NLPHL publications that evaluated the role of rituximab in the frontline and relapsed setting, described the relative incidence of transformation to aggressive B-cell lymphomas, weighed the benefit of addition of chemotherapy to radiation treatment for patients with early-stage disease, considered what should be the preferred chemotherapy regimen for advanced-stage disease, and even assessed the potential role of autologous stem cell transplantation for the management of relapsed disease. General themes within the consensus guidelines include the role for radiation treatment as a monotherapy for early-stage disease, the value of large B-cell lymphoma–directed regimens for transformed disease, the utility of rituximab for treatment of relapsed disease, and, in the pediatric setting, the role of surgical management alone for patients with early-stage disease. |
URI: | http://220.231.117.85:8000/handle/DHKTYTHD_123/374 |
Bộ sưu tập | Huyết học = Hematology |
Danh sách tệp tin đính kèm:
Tên tệp tin | Mô tả tệp tin | Dung lượng | Định dạng | |
---|---|---|---|---|
Hematology-2013-Fanale-406-13.pdf Restricted Access | 750.29 kB | Adobe PDF | Gửi yêu cầu |
Khi sử dụng tài liệu trong thư viện số bạn đọc phải tuân thủ đầy đủ luật bản quyền.